Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02692560
Other study ID # 1R21AG043853
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 2016
Est. completion date February 2017

Study information

Verified date May 2018
Source Kaiser Permanente
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators are doing a study to learn how to support patients aged 60+ in taking more breaks from sitting and reducing total sitting time. The goal of the study is to find out if a sitting time reduction intervention reduces sitting time compared with a control group.


Description:

More than one-third of American adults over 60 have a body mass index > 30 kg/m2. These older adults have more sedentary time than any other group -- an average of 10-11 hours per day. Reducing the sedentary behavior of older adults with obesity, rather than only promoting more intensive physical activity, could provide a more feasible approach to health promotion.

This randomized control pilot trial will evaluate a 12-week intervention to decrease sitting time and increase standing time and light physical activity among sedentary older adults a body mass index > 30 kg/m2 as compared to control group. Baseline and 12-week measurements include anthropometric measures, blood draw by finger stick, cardiovascular health assessments, physical function tasks, and a survey. The intervention will consist of two in-person visits with a health coach followed by phone-based coaching.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date February 2017
Est. primary completion date February 2017
Accepts healthy volunteers No
Gender All
Age group 60 Years to 89 Years
Eligibility Inclusion Criteria:

- Kaiser Permanente Washington enrollees

- Men and women

- Age 60 - 89

- BMI 30 - 50 (calculated based on most recent height ever and most recent weight taken within previous 18 months)

- Primary care within Integrated Group Practice

- Continuously enrolled at Kaiser Permanente Washington for previous 12 months

- No record of death

- Not on the No Contact list

- Speaks and writes English

- Able to hold a conversation by phone (no hearing or other limitations)

- Self-reported sitting time of 6 hours/day or more

- Self-reported ability to stand with or without an assistive device

- Self-reported ability to walk one block with or without an assistive device

- Available for the study duration

- Able to come to Kaiser Permanente Washington Health Research Institute's research clinic for measurement visits

- Willing to wear study activity monitors

Exclusion Criteria:

- Resides in long-term care, hospice care, or skilled nursing facility (previous 12 months)

- Wheelchair bound

- Diagnosis of dementia, serious mental health disorder, or substance use disorder (previous 24 months)

- Use of an assistive device

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
I-STAND
Participants receive health coaching, a workbook, an inactivity alert wristband, and feedback charts based on objective measurement of sedentary time.
Other:
Healthy Living
Participants receive enhanced usual care based on general healthy living topics that are available to all Kaiser Permanente Washington enrollees.

Locations

Country Name City State
United States Kaiser Permanente Washington Health Research Institute Seattle Washington

Sponsors (1)

Lead Sponsor Collaborator
Kaiser Permanente

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in Hours of Sitting Time Average hours of sitting time over the last 7 days measured at baseline and 12 weeks later 12 weeks
Secondary Sit-to-stand Transitions Change in average daily number of activPAL-measured sit-to-stand transitions, from baseline to 12 weeks 12 weeks
Secondary Periods of Sitting for 30+ Minutes Change in average daily number of activPAL-measured periods of sitting for 30+ minutes without standing, from baseline to 12 weeks 12 weeks
Secondary Physical Function Change in Short Physical Performance Battery (SPPB) scale score, from baseline to 12 weeks. The range of scores is 0 to 12, higher values represent better physical function. 12 weeks
Secondary Blood Pressure (Systolic Blood Pressure) Change in average of second and third blood pressure reading (for systolic blood pressure), from baseline to 12 weeks 12 weeks
Secondary Fasting Glucose (mg/dL) Change in fasting glucose (mg/dL) from finger stick blood draw, from baseline to 12 weeks 12 weeks
Secondary Total Cholesterol (mg/dL) Change in total cholesterol (mg/dL) from finger stick blood draw, from baseline to 12 weeks 12 weeks
Secondary Depressive Symptoms Change in Patient Health Questionnaire (PHQ-8) scale score, from baseline to 12 weeks. The scale range is 0 to 24 with higher scores representing higher depressive symptoms. Scores of 10 or more are considered major depression. 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2